Vivani Medical Statistics
Total Valuation
Vivani Medical has a market cap or net worth of $93.46 million. The enterprise value is $92.17 million.
| Market Cap | 93.46M |
| Enterprise Value | 92.17M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Vivani Medical has 54.98 million shares outstanding. The number of shares has increased by 32.98% in one year.
| Shares Outstanding | 54.98M |
| Shares Change (YoY) | +32.98% |
| Shares Change (QoQ) | +0.60% |
| Owned by Insiders (%) | 45.57% |
| Owned by Institutions (%) | 6.29% |
| Float | 30.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.50 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.03, with a Debt / Equity ratio of 1.00.
| Current Ratio | 4.03 |
| Quick Ratio | n/a |
| Debt / Equity | 1.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -87.20% and return on invested capital (ROIC) is -65.04%.
| Return on Equity (ROE) | -87.20% |
| Return on Assets (ROA) | -50.50% |
| Return on Capital (ROIC) | -65.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$583,000 |
| Employee Count | 44 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.15% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | +69.15% |
| 50-Day Moving Average | 1.85 |
| 200-Day Moving Average | 1.24 |
| Relative Strength Index (RSI) | 40.37 |
| Average Volume (30 Days) | 3,148,769 |
Short Selling Information
The latest short interest is 871,114, so 1.58% of the outstanding shares have been sold short.
| Short Interest | 871,114 |
| Short Previous Month | 938,797 |
| Short % of Shares Out | 1.58% |
| Short % of Float | 2.84% |
| Short Ratio (days to cover) | 0.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -26.97M |
| Pretax Income | -25.65M |
| Net Income | -25.65M |
| EBITDA | -24.39M |
| EBIT | -25.65M |
| Earnings Per Share (EPS) | -$0.50 |
Balance Sheet
The company has $21.99 million in cash and $20.70 million in debt, giving a net cash position of $1.30 million or $0.02 per share.
| Cash & Cash Equivalents | 21.99M |
| Total Debt | 20.70M |
| Net Cash | 1.30M |
| Net Cash Per Share | $0.02 |
| Equity / Book Value | 20.76M |
| Book Value Per Share | 0.38 |
| Working Capital | 17.34M |
Cash Flow
In the last 12 months, operating cash flow was -$23.70 million and capital expenditures -$887,000, giving a free cash flow of -$24.59 million.
| Operating Cash Flow | -23.70M |
| Capital Expenditures | -887,000 |
| Free Cash Flow | -24.59M |
| FCF Per Share | -$0.48 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Vivani Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.98% |
| Shareholder Yield | -32.98% |
| Earnings Yield | -27.45% |
| FCF Yield | -26.31% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 19, 2022. It was a reverse split with a ratio of 1:3.
| Last Split Date | Aug 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |